弥漫大B细胞淋巴瘤中ATF-2的表达及意义OACSTPCD
Evaluation of ATF-2 expression and its clinical significance in DLBCL
目的:探索活化转录因子2(Activating Transcription Factor-2,ATF-2)在弥漫大B细胞淋巴瘤中的表达,并分析其与临床特征的关系.方法:收集79例弥漫大B细胞淋巴瘤病理标本,应用免疫组织化学染色方法检测ATF-2蛋白表达.分析ATF-2蛋白表达程度与弥漫大B细胞淋巴瘤患者临床特征之间的关系.结果:ATF-2蛋白在弥漫大B细胞淋巴瘤中表达的阳性率为81.0%(64/79).结合临床病理特征,ATF-2的表达与性别、年…查看全部>>
Objective: To detect activating transcription factor-2 (ATF-2) expression in diffuse large B-cell lymphoma (DLBCL) and its relationship with clinicopathological significance.Methods: Pathological diagnosis and clinical data were collected in DLBCL.Immunohistochemical (IHC) was applied for ATF-2 expression in DLBCL.Results: Positive rate of ATF2 expression in DLBCL was 81% (64/79).ATF2 expression was not related to gender, age, clinical staging, immunol…查看全部>>
吉训秀;郝新宝
海南医学院第一附属医院,海南 海口 570102海南医学院第一附属医院,海南 海口 570102
医药卫生
ATF-2弥漫大B细胞淋巴瘤Bcl-6免疫组织化学
ATF-2DLBDLBcl-6Immunohistochemical
《海南医学院学报》 2017 (9)
1259-1261,3
PEC方案节律化疗对复发难治性NHL患者血清VEGE、 CECs水平的影响(琼卫2010重点-19)It is supported by Hainan Provincial Commission of Health and Family Planning Key Project with No.2010-19.
评论